Azelastin POS® Nasenspray - saisonale allergische Rhinitis
Product Details & Mandatory Information
For the symptomatic treatment of hay fever (seasonal allergic rhinitis).
What is it intended for?
Azelastin POS® 1 mg/ml nasal spray is a medicinal product for the symptomatic treatment of hay fever, so-called seasonal allergic rhinitis.
The nasal spray contains the active ingredient azelastine hydrochloride and is suitable for adults and children aged 6 years and older.
Azelastin POS® can alleviate typical nasal allergy symptoms such as sneezing, a runny or stuffy nose, and itching. Relief from allergic symptoms can begin within just a few minutes of use.
Properties and effect
Azelastin POS® contains the anti-allergic active ingredient azelastine hydrochloride.
Azelastine belongs to the group of antihistamines. During an allergic reaction, the body releases histamine, among other things. This substance is significantly involved in typical allergic complaints. Azelastine inhibits the effect of histamine and can thereby alleviate the symptoms of allergic rhinitis.
Azelastin POS® is characterized by the following properties:
-
For the symptomatic treatment of hay fever
-
Active ingredient: Azelastine hydrochloride
-
Relief of allergic symptoms in just a few minutes
-
Preservative-free
-
High yield
-
Suitable for adults and children aged 6 years and older
-
Shelf life of 6 months after opening
Area of application
Azelastin POS® is used for the symptomatic treatment of hay fever (seasonal allergic rhinitis).
Hay fever is triggered by an allergic reaction to pollen. Typical complaints may include sneezing, itching in the nose, a runny nose, or obstructed nasal breathing.
Through local application as a nasal spray, the active ingredient reaches the nasal mucosa directly.
Application and dosage
Use Azelastin POS® nasal spray according to the instructions in the package leaflet or as directed by your doctor or pharmacist.
The nasal spray is intended for use in the nose.
Ensure correct handling of the spray mechanism during use and avoid contact between the spray nozzle and other surfaces.
If you are unsure about the correct application or dosage, ask your doctor or pharmacist.
Who is it suitable for?
Azelastin POS® nasal spray is suitable for adults and children aged 6 years and older.
It serves for the symptomatic treatment of seasonal allergic nasal complaints, particularly hay fever.
Shelf life after opening
Once opened, Azelastin POS® nasal spray has a shelf life of 6 months.
The date of first use can be noted on the packaging to make it easier to monitor the shelf life after opening.
Important information
Azelastin POS® 1 mg/ml nasal spray is a medicinal product.
The preparation is intended for the symptomatic treatment of hay fever (seasonal allergic rhinitis).
Suitable for adults and children aged 6 years and older.
The nasal spray is preservative-free.
The preparation has a shelf life of 6 months after opening.
Read the package leaflet before use and pay particular attention to the information on dosage, contraindications, precautions, and interactions.
For risks and side effects, read the package leaflet and ask your doctor or pharmacist.
Status of product information: November 2021.
Distribution: URSAPHARM GmbH, Inkustraße 1–7/7, 3400 Klosterneuburg.
Ingredients
Active ingredient:
-
Azelastine hydrochloride
Azelastin POS® contains 1 mg of azelastine hydrochloride per ml of nasal spray solution.
The preparation is preservative-free.
For further ingredients, please refer to the current package leaflet.
Side effects and tolerance
Like all medicines, Azelastin POS® can have side effects, although not everyone will experience them.
For a complete list of possible side effects and their frequencies, please refer to the current package leaflet.
If unusual or severe complaints occur during use, or if allergic symptoms worsen despite treatment, contact your doctor or pharmacist.
Delivery time: approx. 3-4 days (international shipping varies)
Azelastin POS® Nasenspray - saisonale allergische Rhinitis
Customer Reviews
- Similar Products
- Recently viewed